Understand the source comparison
Best Peptides for Memory Improvement: Mechanism Comparison
Semax BDNF upregulation via melanocortin receptor binding Human RCTs in healthy adults 600mcg intranasal 2× daily, 14–28 days Intranasal (olfactory pathway) Strongest evidence for near-term memory retention improvement in cognitively normal populations. Docume
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Semax
- BDNF upregulation via melanocortin receptor binding
- Human RCTs in healthy adults
- 600mcg intranasal 2× daily, 14–28 days
- Intranasal (olfactory pathway)
- Strongest evidence for near-term memory retention improvement in cognitively normal populations. Documented receptor specificity.
- Selank
- Anxiolytic via GABA modulation; indirect cognitive benefit through stress reduction
- Human trials in anxiety disorders; limited memory-specific data
- 300–600mcg intranasal 2× daily, 14 days
- Intranasal
- Indirect cognitive benefit. Reduces anxiety-related memory impairment rather than enhancing baseline memory capacity.
- Cerebrolysin
- Neurotrophic peptide delivery (NGF, CNTF, GDNF)
- Meta-analyses in vascular dementia; modest effect sizes
- 10–30mL cumulative dose IV over 2–4 weeks
- Intravenous or intramuscular
- Clinical benefit demonstrated in impaired populations (stroke, dementia). Less evidence for enhancement in healthy adults.
- Dihexa
- HGF receptor agonist; promotes synaptogenesis
- Preclinical only (no human trials)
- N/A (not approved for human use)
- Expected: intranasal or oral (lipophilic structure)
- Strongest preclinical data for structural synaptic enhancement, but zero human safety or efficacy data as of 2026.